SD-OCT Guided Treatment of Fungal Chorioretinitis

Outcome of SD-OCT Guided Oral Anti-fungal Treatment of Fungal Chorioretinitis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04947592

Enrollment

Registered

2021-07-01

Start date

2020-01-15

Completion date

2022-01-31

Last updated

2021-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal Retinitis

Keywords

fungal, chorioretinitis, OCT

Brief summary

Fungal Chorioretinitis is a vision threatening condition.The investigators evaluate the efficacy of SD-OCT role in the treatment

Detailed description

Baseline ,and postoperative 1 ,6 and 12 months full ophthalmic examination and SD-OCT was done.Procedure included oral fluconazole treatment 1 tablet once for 14 days

Interventions

DRUGFluconazole 150 mg

fluconazole 150 MG once daily for 14 days

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- fungal chorioretinitis

Exclusion criteria

* vitritis * other macular lesion * macular scar

Design outcomes

Primary

Measure	Time frame	Description
Best corrected visual acuity (BCVA)	6 months	Change in BCVA in LOG MARS(logarithm minimum angle of resolution

Secondary

Measure	Time frame	Description
optical coherence tomography (OCT) foveal thickness	6 months	change in foveal thickness measured in micrometer

Countries

United Arab Emirates

Contacts

Primary ContactTAREK R ELHAMAKY, MD

thamaky@ibnnafees.com0503207889

Backup ContactTAREK ELHAMAKY